NasdaqCM - Delayed Quote USD

Xenetic Biosciences, Inc. (XBIO)

4.0899 +0.3199 (+8.49%)
At close: 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,539.9860
2,539.9860
1,706.9250
1,160.6920
436.9420
Operating Expense
7,055.7010
7,055.7010
8,424.8330
6,907.4570
5,131.4770
Operating Income
-4,515.7150
-4,515.7150
-6,717.9080
-5,746.7650
-4,694.5350
Net Non Operating Interest Income Expense
355.7570
355.7570
167.1520
100.4670
126.1710
Other Income Expense
25.3800
25.3800
-1.5970
1.1190
-9,243.6200
Pretax Income
-4,134.5780
-4,134.5780
-6,552.3530
-5,645.1790
-13,811.9840
Tax Provision
--
--
--
--
-2,918.5180
Net Income Common Stockholders
-4,134.5780
-4,134.5780
-6,552.3530
-5,645.1790
-10,893.4660
Diluted NI Available to Com Stockholders
-4,134.5780
-4,134.5780
-6,552.3530
-5,645.1790
-10,893.4660
Basic EPS
-2.71
--
-4.61
-5.50
-17.00
Diluted EPS
-2.71
--
-4.61
-5.50
-17.00
Basic Average Shares
1,528.2100
--
1,422.4430
1,027.9400
639.2380
Diluted Average Shares
1,528.2100
--
1,422.4430
1,027.9400
639.2380
Total Operating Income as Reported
-4,515.7150
-4,515.7150
-6,717.9080
-5,746.7650
-13,937.6630
Total Expenses
7,055.7010
7,055.7010
8,424.8330
6,907.4570
5,131.4770
Interest Income
355.7570
355.7570
167.1520
100.4670
126.1710
Net Interest Income
355.7570
355.7570
167.1520
100.4670
126.1710
Net Income from Continuing & Discontinued Operation
-4,134.5780
-4,134.5780
-6,552.3530
-5,645.1790
-10,893.4660
Normalized Income
-4,134.5780
-4,134.5780
-6,552.3530
-5,645.1790
-3,603.4416
EBIT
-4,515.7150
-4,515.7150
-6,717.9080
-5,746.7650
-4,694.5350
EBITDA
-4,515.7150
-4,515.7150
-6,690.8650
-5,711.2830
-4,665.6980
Reconciled Depreciation
--
--
27.0430
35.4820
28.8370
Net Income from Continuing Operation Net Minority Interest
-4,134.5780
-4,134.5780
-6,552.3530
-5,645.1790
-10,893.4660
Total Unusual Items Excluding Goodwill
--
--
--
--
-9,243.1280
Total Unusual Items
--
--
--
--
-9,243.1280
Normalized EBITDA
-4,515.7150
-4,515.7150
-6,690.8650
-5,711.2830
4,577.4300
Tax Rate for Calcs
--
--
--
--
0.0002
Tax Effect of Unusual Items
--
--
--
--
-1,953.1036
12/31/2020 - 6/30/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VRPX Virpax Pharmaceuticals, Inc.
3.1000
+8.01%
 
AKTX Akari Therapeutics, Plc
1.1850
+1.28%
 
REVB Revelation Biosciences, Inc.
2.1800
+2.83%
 
VTVT vTv Therapeutics Inc.
26.97
+2.18%
 
HOTH Hoth Therapeutics, Inc.
1.1600
0.00%
 
NRBO NeuroBo Pharmaceuticals, Inc.
3.1400
+2.61%
 
KTTA Pasithea Therapeutics Corp.
7.24
0.00%
 
FWBI First Wave BioPharma, Inc.
2.7400
+0.37%
 
SPRC SciSparc Ltd.
1.3200
+4.76%
 
ADTX Aditxt, Inc.
2.3900
-5.53%